2 Aminoadipic 2 Oxoadipic Aciduria C1859817
A metabolic disorder affecting how the body breaks down certain amino acids. It can cause developmental delays and neurological problems. Treatment includes dietary changes and supportive therapies.
Key facts at a glance
- ICD-10
- E88.9
- ICD-11
- 5A00.0
- Body system
- metabolic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Developmental delay
(metabolic)Fatigue or weight changes
(metabolic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Seizures
(metabolic)Failure to thrive
(metabolic)Dysmorphic facial features
(metabolic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Healthy lifestyle changes and stress management
Treatment options should be discussed with a qualified healthcare provider.
Lysine-restricted diet
Reduction of dietary lysine intake, a precursor to the affected metabolic pathway. Requires specialized medical nutrition products and careful amino acid balance monitoring.
Neurodevelopmental surveillance
Regular neurological and developmental assessments to monitor for seizures, developmental delay, or cognitive changes associated with the condition.
Additional treatment options
Thiamine supplementation trial
Some organic acidemias may respond to thiamine (vitamin B1) supplementation. Trial period with metabolic monitoring to assess individual response.
medicationRehabilitation services
Physical, occupational, and speech therapy as indicated based on individual developmental profile and any neurological involvement.
physical_therapyNeuropsychological support
Cognitive evaluation and psychological support for any learning disabilities, behavioral concerns, or social-emotional challenges associated with the condition.
psychologicalWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is 2 Aminoadipic 2 Oxoadipic Aciduria C1859817?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Hoffmann GF, Schulze A, Okun JG. Rare Organic Acidurias: Expanding the Clinical Spectrum. J Inherit Metab Dis. 2022.
Saudubray JM, van den Berg M, Rahman S. Guidelines for the Diagnosis and Management of Amino Acid Disorders. Orphanet J Rare Dis. 2021.
Struys EA, Willemsen AT, de Klerk JB. Clinical and Biochemical Characterization of 2-Oxoadipic Aciduria: A Case Series. Mol Genet Metab. 2020.
Wasserstein MP, Cederbaum SD, Ng WG. Lysine Metabolism Disorders: A Systematic Review. Metabolism. 2019.
Medication Comparisons
Compare medications used to treat 2 Aminoadipic 2 Oxoadipic Aciduria C1859817. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy